Delivery Order SPE2DB20D3101-SPE2DB23FQXT2

Award Date 12/15/22
Potential Completion Date 12/16/22
Potential Value $5.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,774.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Sprycel 140 mg tablets, a specialty pharmaceutical product, with a completion date of January 16, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $29,285.55 firm fixed-price delivery order is for the pharmaceutical product Sprycel 100 mg Tablet 30s. This order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $14,506.59 firm fixed-price delivery order is for the pharmaceutical product Sprycel 100 mg tablet, with a completion date of September 7, 2023. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,769.38 firm fixed price delivery order is for the supply of the prescription drug Sprycel 50 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November...
This federal contract award, valued at $93,455.49, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the pharmaceutical product Sprycel (100 mg tablet, 30 count) and has a completion date of February 8, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
This federal contract award with the Defense Logistics Agency (DLA) is for the delivery of Sprycel 100 MG Tablets in a 30-count package. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical supplier to the U.S. federal government, on June 28, 2024. The firm-fixed-price delivery order has a ceiling value of $26,750.22 and an ultimate completion date of July 1, 2024. This contract is not designated as a set-aside. Amerisourcebergen, through its Corporate Office Division,...
This federal contract award, valued at $9,441.81, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product Sprycel 50 mg tablets. The award has a completion date of February 6, 2024 and is a firm fixed-price contract. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a delivery order with a firm fixed price valued at $10,645.34, for the supply of Sprycel 100 mg tablets. The ultimate completion date for this award is March 26, 2024. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $38,410.93 for the pharmaceutical product SPRYCEL 100 MG TABLET 30S. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has a period of performance ending on November 20, 2023 and utilizes a firm fixed price pricing type. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is a Firm Fixed Price delivery order for the pharmaceutical product Sprycel 140 mg tablets, with a ceiling value of $12,028.56 and a performance period through April 1, 2024. The contract does not have any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, serves as a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FQXT2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sprycel 140 mg tablets. The award, valued at $5,384.28, is a firm fixed-price delivery order with a completion date of December 16, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that serves as a critical supplier of pharmaceutical products and medical supplies to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of medical commodities to support military and veteran healthcare programs globally.

Generated 2/27/25, 11:16 AM